channel 7 news exclusive: imugene licenses car t directed ov therapy for solid tumours
Published 3 years ago • 2.9K plays • Length 1:24Download video MP4
Download video MP3
Similar videos
-
1:26
channel 7 news exclusive
-
4:07
combination car t oncolytic virus immunotherapy kills tumors
-
29:19
imugene celularity announce an exclusive strategic partnership to develop a novel oncolytic virus.
-
6:16
imugene's new cancer therapy cd19 (oncarlytics) considered the 'holy grail'
-
4:12
imugene's ceo interviewed on ausbiz detailing a clinical trial deal with merck germany and pfizer.
-
30:02
imugene's science series featuring the oncolytic viraltherapy checkvacc
-
4:45
leslie chong's first interview following our news imugene secured two fda ind approvals
-
19:06
imugene's founder and executive chairman's keynote speech at emerging small caps summit 2021
-
44:28
imugene investor presentation | non-deal roadshow 2023 australia
-
2:18
7 news australia | australian company imugene; saving lives using a cancer eating virus
-
16:12
a clinical stage immuno-oncology company.
-
5:35
imugene's leslie chong outlines key strategic partnership with celularity
-
8:29
imugene's leslie chong details eureka therapeutics collaboration
-
6:40
imugene doses first patient in vaxinia phase 1 trial
-
0:36
imugene's science series: checkvacc with professor yuman fong and dr. yuan yuan.
-
14:02
imugene (asx: imu) – new global partnership announced for this leading asx biotech
-
6:15
imugene ceo hails clinical milestone for her-vaxx cancer immunotherapy
-
4:27
imugene pd1 vaxx 1080p
-
4:49
imugene her-vaxx video asx: imu | an emerging leader in cancer immuno-oncology
-
5:27
imugene's leslie chong welcomes ind approval for checkvacc trial
-
5:42
july 8 2019 her-vaxx esmo interview | proactive investors
-
29:41
infinity series with imugene chairman paul hopper asx: imu